From Texas Health and Human Services Commission <[email protected]>
Subject Change in PDL Status for Intranasal Rhinitis Agents Drug Class, Effective Sept. 29, 2025
Date October 6, 2025 1:03 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Having trouble viewing this email? View it as a Web page [ [link removed] ].






HHS Logo [ [link removed] ]









Change in PDL Status for Intranasal Rhinitis Agents Drug Class, Effective Sept. 29, 2025

Texas Medicaid removed the non-preferred status [ [link removed] ] for certain generic azelastine/fluticasone nasal products on the Texas Preferred Drug List following a drug shortage on brand Dymista products.

*Other News*


* Columbus Day Holiday to Delay Pharmacy Payments [ [link removed] ]
* HHSC to Participate in Cell and Gene Therapy Access Model [ [link removed] ]
* Temporary Non-preferred Drug Status Begins Sept. 1, 2025 [ [link removed] ]

*Outreach and Training Reminders*


* Pharmacies Must Ensure Contact Information Is Current in PEMS [ [link removed] ]
* Drug Shortage and Expedited Formulary, Preferred Drug List Addition Notification Available [ [link removed] ]
* Texas Health Steps Includes Pharmacy Education Opportunities [ [link removed] ]
















________________________________________________________________________

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website [ [link removed] ].

________________________________________________________________________

Stay Connected Visit us on Facebook [ [link removed] ] Visit us on YouTube [ [link removed] ] Visit us on X [ [link removed] ] Visit us on Instagram [ [link removed] ] Visit us on Facebook [ [link removed] ]  (en español)  

Bookmark and Share [ [link removed] ]

Subscriber Services
Manage Preferences [ [link removed] ]  |  Unsubscribe [ [link removed] ]  |  Help [ [link removed] ]

________________________________________________________________________

This email was sent to [email protected] using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202 GovDelivery logo [ [link removed] ]

body .abe-column-block { min-height: 5px; } table.gd_combo_table img {margin-left:10px; margin-right:10px;} table.gd_combo_table div.govd_image_display img, table.gd_combo_table td.gd_combo_image_cell img {margin-left:0px; margin-right:0px;} table.govd_hr {min-width: 100%;}
Screenshot of the email generated on import

Message Analysis